AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danet, I.-M.
Right arrow Articles by Kanematsu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danet, I.-M.
Right arrow Articles by Kanematsu, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2003; 181:809-817
© American Roentgen Ray Society


Spectrum of MRI Appearances of Untreated Metastases of the Liver

Ioana-Maria Danet1, Richard C. Semelka1, Polytimi Leonardou1, Larissa Braga1, Georgeta Vaidean2, John T. Woosley3 and Masayuki Kanematsu1

1 Department of Radiology, University of North Carolina at Chapel Hill, CB 7510, Chapel Hill, NC 27599-7510.
2 Department of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7510.
3 Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7510.

OBJECTIVE. The purpose of our study was to identify the spectrum of MRI appearances of untreated liver metastases from different primary origins.

MATERIALS AND METHODS. Over a period of 52 months, we used our clinical information system to retrospectively identify the first MRIs obtained in 165 consecutive patients who had untreated liver metastases. All patients had histologic confirmation of the primary tumor. Liver metastases were confirmed at histologic examination, on imaging, or at clinical follow-up. MR sequences used included T1-weighted spoiled gradient-echo, T2-weighted half-Fourier acquisition single-shot turbo spin-echo, and serial gadolinium-enhanced spoiled gradient-echo imaging. Size, signal intensity characteristics, and pattern of enhancement of the metastases on MRIs were evaluated by two radiologists in consensus. Lesions were categorized by size: smaller than 1.5 cm, between 1.5 and 3.0 cm, and larger than 3.0 cm.

RESULTS. A total of 516 metastases (size range, 5-120 mm; mean, 28 mm) were assessed. Fifty-nine patients had hypervascular lesions, and 106 patients had hypovascular lesions. A significant difference in proportion of tumor vascularity was observed between the primary tumors described as classically hypervascular and those described as classically hypovascular (chi-square test for proportions of 70.8, p < 0.0001). The most common pattern was peripheral ring (72% of patients) seen on the arterial dominant phase images, with incomplete central progression (63%) seen on the delayed phase images. A hypointense ring seen in the periphery of the tumor during the delayed phase was the most common appearance in hypervascular metastases (27% patients) and was particularly conspicuous in patients with neuroendocrine and carcinoid tumors. Perilesional enhancement was common (47%), mostly seen in hypovascular metastases (92%). Generally, large lesions tended to show a peripheral ring or heterogeneous enhancement, and small lesions showed homogeneous enhancement.

CONCLUSION. MRI allows the identification of a wide spectrum of appearances of untreated liver metastases. The extent and pattern of enhancement of various histologic types of tumor are depicted on MRI.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
T. Parikh, S. J. Drew, V. S. Lee, S. Wong, E. M. Hecht, J. S. Babb, and B. Taouli
Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging
Radiology, March 1, 2008; 246(3): 812 - 822.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
F. Hughes-Cassidy, J. Wong, D. Aguirre, A. D. Chavez, T. Wolfson, A. Gamst, and C. Sirlin
Transient Homogeneously Enhancing Hepatic Masses: Can Size Predict Benignity?
Am. J. Roentgenol., February 1, 2008; 190(2): 300 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Giraudet, D. Vanel, S. Leboulleux, A. Auperin, C. Dromain, L. Chami, N. Ny Tovo, J. Lumbroso, N. Lassau, G. Bonniaud, et al.
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4185 - 4190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. Kanematsu, S. Goshima, H. Kondo, Y. Tsuge, R. Yokoyama, K. Kajita, M. Onozuka, Y. Suzuki, M. Van Cauteren, and N. Moriyama
Gadolinium-Enhanced Multiphasic 3D MRI of the Liver with Prospective Adaptive Navigator Correction: Phantom Study and Preliminary Clinical Evaluation
Am. J. Roentgenol., April 1, 2007; 188(4): W309 - W316.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
K. M. Elsayes, V. R. Narra, Y. Yin, G. Mukundan, M. Lammle, and J. J. Brown
Focal Hepatic Lesions: Diagnostic Value of Enhancement Pattern Approach with Contrast-enhanced 3D Gradient-Echo MR Imaging
RadioGraphics, September 1, 2005; 25(5): 1299 - 1320.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. Grazioli, G. Morana, M. A. Kirchin, and G. Schneider
Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine-enhanced MR Imaging: Prospective Study
Radiology, July 1, 2005; 236(1): 166 - 177.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.